Showing results (501-510 of 514) with videos related to

Sort By:
Pageof 52
Blood|April 14, 2012
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitorsDaniel Gonzalez-Nieto, Lina Li, Anja Kohler, et al.
Bioorganic & Medicinal Chemistry|February 22, 2008
Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysisMark D Rosen, Michael D Hack, Brett D Allison, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2011
JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailabilityMagda F Morton, Terrance D Barrett, Jamie Freedman, et al.
Journal of Hypertension|August 29, 2023
99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heartBoqia Xie, Lina Li, Mingming Lin, et al.
Science (New York, N.Y.)|December 21, 2023
Dealuminated Beta zeolite reverses Ostwald ripening for durable copper nanoparticle catalystsLujie Liu, Jiaye Lu, Yahui Yang, et al.
Human Gene Therapy|June 19, 2026
Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory MeetingsRodica Stan, Richa Madan Lomash, Oleg A Shchelochkov, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemiaPetr O Ilyinskii, Alicia M Michaud, Gina L Rizzo, et al.
Human Gene Therapy|February 20, 2025
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy ProgramRicha Madan Lomash, Jean Dehdashti, Oleg A Shchelochkov, et al.
Nature Chemistry|March 19, 2024
High-throughput and proteome-wide discovery of endogenous biomolecular condensatesPengjie Li, Peng Chen, Fukang Qi, et al.
Journal of Medicinal Chemistry|October 13, 2006
Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonistsBrett D Allison, Victor K Phuong, Laura C McAtee, et al.
Pageof 52